Physician profile
John Vance
NPI 1659639888
$19,729.23
in general payments reported to CMS, 2019-2025
35 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,495 · 2020: $1,744 · 2021: $391 · 2022: $7,891 · 2023: $129 · 2024: $3,598 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,122 · Travel and Lodging: $2,009 · Education: $76.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,122.42 |
| Travel and Lodging | $2,009.25 |
| Education | $76.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,371.08 | 2019-2025 | |
| Davol INC. | $2,799.64 | 2020-2024 | Phasix Mesh |
| Angiodynamics, INC. | $2,154.33 | 2019 | |
| Medical Device Business Services, INC. | $1,357.11 | 2020 | |
| Conmed Corporation | $639.00 | 2021-2022 | |
| Ethicon US, LLC | $191.79 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $161.49 | 2024-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Access Pro Medical, LLC | $134.39 | 2025 | Matriderm |
| Medtronic, INC. | $108.98 | 2021-2025 | Progrip, Transorb, Parietene Ds |
| Baxter Healthcare | $89.36 | 2021 | |
| Olympus America INC. | $60.58 | 2020 | |
| Osiris Therapeutics INC. | $54.42 | 2019 | |
| Boston Scientific Corporation | $53.42 | 2022-2025 | General - Ultrasound |
| Lemaitre Vascular, INC. | $52.94 | 2019-2025 | Artegraft Vascular Graft |
| Astrazeneca Pharmaceuticals Lp | $50.46 | 2023 | Andexxa |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $48.26 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $38.81 | 2021-2022 | |
| Elucent Medical | $31.09 | 2025 | |
| Teleflex LLC | $30.91 | 2021 | |
| Mesh Suture INC | $28.27 | 2025 | |
| Convatec INC. | $27.28 | 2022 | |
| Leica Microsystems INC. | $25.88 | 2022 | |
| Cardiovascular Systems INC. | $24.46 | 2019 | |
| Bard Peripheral Vascular, INC. | $21.60 | 2023 | Venclose Maven Catheter |
| Merit Medical Systems INC | $19.05 | 2023 | Savi Scout |
| Kci USA, INC. | $18.89 | 2022 | |
| Daiichi Sankyo INC. | $18.81 | 2023 | Injectafer |
| Hologic Sales and Service, LLC | $18.77 | 2023 | Localizer, Trunode, Trident Specimen Radiography System |
| Elutia, INC. | $16.34 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.99 | 2020 | |
| Stryker Corporation | $14.36 | 2020 | |
| Aroa Biosurgery Incorporated | $13.63 | 2019 | |
| Clinical Technology, INC | $13.49 | 2025 | Vascular Product |
| Smith+Nephew, INC. | $13.46 | 2020 | |
| Shire North American Group INC | $11.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vance listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.